Autologous Conditioned Plasma (ACP) and Osteoarthritis of the Knee: A Review of Current Clinical Evidence
In brief
A review of clinical studies on autologous conditioned plasma (ACP), a type of platelet-rich plasma, for knee osteoarthritis. Patient-reported scores improved across the studies, but in routine practice the gains did not reach the threshold patients would usually notice as meaningful. The authors call for larger trials and real-world studies.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Autologous Conditioned Plasma (ACP) and Osteoarthritis of the Knee: A Review of Current Clinical Evidence Authors: Ashim Gupta & Vijay Jain Link: https://pubmed.ncbi.nlm.nih.gov/38384614/ Year of Publication: 2024
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

